Genzyme Sues TKT Over Biotech Patent In Israeli Court
Barely a year and a half after Genzyme Corp. and Transkaryotic Therapies Inc. settled their patent disputes with a vow to spend less time in court, the two biotech companies are...To view the full article, register now.
Already a subscriber? Click here to view full article